High quality of 58-month life in lung cancer patient with brain metastases sequentially treated with gefitinib and osimertinib

Abstract: Brain metastases (BMs) and bone metastases seriously affect the prognosis of lung cancer patients. How to optimize the use of existing targeted drugs is an important way to address the clinical needs of the central nervous system in the individualized treatment of non-small cell lung cancer (NSCLC). In this report, we describe an NSCLC patient with BMs who survived for 58 months, which is the longest survival case among lung cancer patients with BMs. The patient was initially diagnosed with lung cancer more than 5 years ago with simultaneous brain, bone, and lung metastases. After gefitinib resistance, she received osimertinib in sequence with no progress for 58 months in total and maintained very good quality of life.

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
Online-Ressource
Language
Englisch

Bibliographic citation
High quality of 58-month life in lung cancer patient with brain metastases sequentially treated with gefitinib and osimertinib ; volume:16 ; number:1 ; year:2021 ; pages:1602-1607 ; extent:6
Open medicine ; 16, Heft 1 (2021), 1602-1607 (gesamt 6)

Creator
Zhang, Ying
Zhang, Xiaowen
Wang, Fang
Feng, Yan
Tang, Huaping

DOI
10.1515/med-2021-0379
URN
urn:nbn:de:101:1-2022092014132217545100
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:31 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Associated

  • Zhang, Ying
  • Zhang, Xiaowen
  • Wang, Fang
  • Feng, Yan
  • Tang, Huaping

Other Objects (12)